The short answer is that plasma contains anticoagulants which chemically cripple the complement system. For complement functional assays like CH50 and AH50, serum is mandatory because common anticoagulants in plasma collection tubes—such as EDTA, citrate, or heparin—either strip away essential mineral cofactors or directly block the enzymatic reactions that the test is designed to measure. Serum, collected in a plain tube without additives, allows the native complement cascade to remain intact, yielding an accurate reading of total functional activity.
The core takeaway is that functional complement testing requires free calcium and magnesium ions. Plasma anticoagulants like EDTA and citrate chelate these divalent cations, while heparin acts as a direct enzymatic inhibitor. Using serum avoids this artificial inactivation, making it the only reliable matrix for CH50 and AH50 assays.
Why the Choice of Matrix Is Non‑Negotiable
The CH50 and AH50 assays measure the functional capacity of the entire classical or alternative complement pathway by challenging it to lyse antibody‑coated erythrocytes. Even a partial loss of activity caused by the sample tube itself will produce a false‑low result, potentially masking a genuine immunodeficiency or misclassifying a patient’s condition.
The Cation Dependency of the Complement Cascade
Calcium is the structural glue of the classical pathway start‑complex. The C1 complex—assembled from C1q, C1r, and C1s—requires Ca²⁺ ions to maintain its molecular integrity and enzymatic function. Without calcium, C1 dissociates and the classical pathway cannot fire.
Magnesium is the ignition key for multiple enzymatic steps. The classical pathway needs Mg²⁺ for C2 activation, while the alternative pathway depends on Mg²⁺ for Factor B activation. Remove magnesium and the entire downstream amplification loop collapses.
How Common Anticoagulants Sabotage This Chemistry
EDTA and citrate are chelators. They bind free Ca²⁺ and Mg²⁺ so tightly that these ions are no longer available for complement proteins. In an EDTA or citrate plasma tube, the C1 complex falls apart and the alternative pathway C3 convertase cannot form, leading to an inert sample long before it reaches the assay plate.
Heparin uses a different destructive mechanism. Instead of cheating cations, heparin directly inhibits the proteolytic activity of complement enzymes. It acts as an enzymatic roadblock, suppressing the cascade even if physiological levels of calcium and magnesium are artificially restored during the assay.
Why Serum Preserves Native Activity
Serum is generated by clotting in the absence of additives. Blood drawn into a plain red‑top tube forms a clot naturally, consuming fibrinogen and leaving behind the liquid portion without any chemical interference.
The clotting process does not deplete complement proteins, and because no anticoagulants are present, the full panel of divalent cations remains at physiological concentrations. This means the sample’s complement system stays dormant yet fully competent until the assay deliberately activates it, reflecting the true in vivo functional reserve.
Understanding the Trade‑offs and Pre‑analytical Pitfalls
Choosing serum solves the anticoagulant problem but introduces its own set of handling requirements. Ignoring these can compromise the assay just as severely as using the wrong matrix.
The Fragility of Fresh Serum
Complement proteins are heat‑labile and degrade rapidly. Functional activity can be lost within hours at room temperature and is sensitive to repeated freeze‑thaw cycles. The sample must be separated from the clot promptly, chilled, and stored at −70°C if testing is not immediate.
Delayed clotting or improper storage can cause in vitro activation. If the sample sits too long before centrifugation, spontaneous activation may consume complement components, yielding a falsely low result just as plasma anticoagulants would.
When Plasma Could Theoretically Be Used—and Why It Rarely Is
Research protocols sometimes employ specialized tubes. For example, hirudin or other non‑interfering thrombin inhibitors can anticoagulate blood without chelating cations or directly inhibiting the cascade. However, these are not standard clinical collection devices and have not been validated for routine diagnostic use.
The risk of pre‑analytical error is unacceptably high in clinical labs. Standardizing on serum collected in plain tubes eliminates variability introduced by different anticoagulant types and concentrations, making it the safest choice for reproducible diagnostic results.
Making the Right Choice for Your Diagnostic Goal
The selection of matrix must align with the intended use of the data. While serum is the universal answer for functional complement assays, the context of the broader diagnostic workup matters.
- If your primary focus is accurate CH50/AH50 functional screening: Use fresh serum collected in a plain red‑top tube, separated promptly, and stored at −70°C. This is the only matrix that preserves both the free‑cation milieu and the full enzymatic potential of the cascade.
- If your focus is complement component quantification (e.g., ELISA for C3, C4): Plasma collected in EDTA can be acceptable because antigenic measurement does not require functional activity. EDTA actually stabilizes some analytes. However, the lab must validate that the anticoagulant does not interfere with the specific immunoassay.
- If your focus is both functional and antigenic testing from the same draw: Collect a serum tube for functional assays and a separate EDTA plasma tube for antigenic tests. There is no universal matrix that satisfies both requirements for complement evaluation.
The key is understanding that a CH50 or AH50 result is only as trustworthy as the sample it comes from. By standardizing on properly handled serum, you remove the most significant pre‑analytical threat to accurately assessing a patient’s complement defense system.
Summary Table:
| Sample Matrix / Additive | Mechanism of Action | Impact on CH50 / AH50 Assay | Matrix Suitability |
|---|---|---|---|
| Serum (Plain Tube) | Preserves physiological Ca²⁺ and Mg²⁺ levels | Native complement cascade remains fully functional | Mandatory (Optimal) |
| EDTA / Citrate Plasma | Chelates essential divalent cations (Ca²⁺, Mg²⁺) | Dissociates C1 complex and prevents C3 convertase formation | Unsuitable (False Low) |
| Heparin Plasma | Directly inhibits proteolytic complement enzymes | Blocks enzymatic cascade steps even with cations present | Unsuitable (False Low) |
Developing robust complement assays or optimizing your IVD workflows? CamelBio provides diagnostic manufacturers, labs, and research institutes with one-stop access to high-quality IVD raw materials, technical services, and expert consulting—covering every stage from concept to clinic. Eliminate pre-analytical risks and achieve superior assay precision—contact our technical team today!